HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Study of optimal posology of penicillamine in the treatment of common rheumatoid polyarthritis (apropos of a personal series of 200 cases)].

Abstract
A comparison of two series of patients with rhe,matic polyarthritis, the one (n = 140) treated with dosage equal to or higher than 900 mg, the other (n = 60) with dosage between 600 and 750 mg, did not reveal significant difference in clinical and biological efficacy. The number of side-effects was not significantly reduced by lower dosage, except for digestive tract disorders. A reduction of dosage does, therefore, not permit less strict supervision and monitoring for side-effects of treatment.
AuthorsJ P Camus, J Crouzet, A Prier, A P Leca
JournalRevue du rhumatisme et des maladies osteo-articulaires (Rev Rhum Mal Osteoartic) Vol. 44 Issue 12 Pg. 721-4 (Dec 1977) ISSN: 0035-2659 [Print] France
Vernacular TitleRecherche d'une posologie optimale de la pénicillamine dans le traitement de la polyarthrite rhumatoïde commune. A propos d'une série personnelle de 200 cas.
PMID609877 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Penicillamine
Topics
  • Arthritis, Rheumatoid (drug therapy)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Penicillamine (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: